S
SLXN
Silexion Therapeutics Corp
1.070
+0.070+7.00%After Hours: 1.070 0.000 0.00%19:36 04/17 EDT
OPEN/PREV CLOSE1.010/1.000
TODAY RANGE1.010-1.070
VOL23.37K
MARKET CAP4.36M
52 WEEK RANGE0.9701-22.36
AVG VOL (3M)46.50K
% TURNOVER0.57%
TURNOVER--
P/E (TTM)-0.1194
% RANGE6.00%
EPS(TTM)-8.9596
P/E(FORWARD)-0.2597
P/B1.285
BVPS0.8325
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.00M
SHARES OUTSTANDING4.07M
NEXT EARNINGS11/12-11/18
FREE FLOAT3.74M
LOT SIZE1
EX-DATE07/29/2025
News
Press Releases
Financial Reports
Profile
TipRanks·03/31 02:05
Top Silexion Executive Quietly Unloads a Chunk of Company Stock
TipRanks·03/25 20:42
Silexion Therapeutics Announces Immediate Board Membership Change
TipRanks·03/24 13:50
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204
TipRanks·03/24 13:33
Silexion gains approval for SIL204 pancreatic cancer trial
TipRanks·03/23 21:09
Silexion Shareholders Reject Capital Increase and Plan Amendments
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.